Welcome to our dedicated page for NU SKIN ENTERPRISES SEC filings (Ticker: NUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NU SKIN ENTERPRISES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NU SKIN ENTERPRISES's regulatory disclosures and financial reporting.
Nu Skin Enterprises Chief Financial Officer Thomas James reported a tax-related share disposition. On the vesting of previously granted restricted stock units, 11,725 shares of Class A common stock were withheld to cover tax obligations at $8.36 per share. After this tax-withholding disposition, he directly owns 180,998 shares of Nu Skin Enterprises Class A common stock.
Nu Skin Enterprises reported that President and CEO Ryan S. Napierski had 49,037 shares of Class A common stock withheld on February 15, 2026 to cover tax obligations from vesting restricted stock units. The shares were valued at $8.36 per share. After this tax-withholding disposition, he directly held 844,354 shares of Class A common stock.
Nu Skin Enterprises reported 2025 revenue of $1.485 billion, down from $1.732 billion in 2024 and $1.969 billion in 2023, reflecting pressure on its core direct-selling business. About 85% of 2025 revenue came from Nu Skin-branded operations and 15% from its Rhyz investment arm.
Beauty products generated $568.1 million (38% of sales) and wellness products $689.1 million (46%), with ageLOC lines contributing meaningful portions in both categories. Rhyz businesses produced $223.6 million, while one Rhyz unit, Mavely, was sold after contributing $69.6 million to 2024 revenue.
Customer, paid affiliate and sales leader counts declined across regions, including Mainland China, where a restrictive and evolving regulatory environment continues to create operational risk. The company highlights extensive global regulatory oversight of direct selling, cosmetics, supplements and devices, including heightened FTC scrutiny of multi-level marketing earnings claims and complex licensing rules in China.
Nu Skin Enterprises executive Justin S. Keisel reported stock awards tied to performance goals. On February 10, 2026, he acquired 2,910 shares of Class A common stock at $0.00 per share, increasing his direct holdings to 93,832 shares.
On the same date, he acquired an additional 34,500 shares at $0.00 per share, bringing his direct ownership to 128,332 shares. Both grants relate to previously awarded restricted stock units that became eligible for vesting after Nu Skin met specified performance criteria from 2024 and 2025 grants.
Nu Skin Enterprises' Chief Product Officer Steven Keith Hatchett reported stock awards tied to performance-based restricted stock units. On February 10, 2026, performance criteria were met for prior RSU grants, resulting in acquisitions of 8,952 and 43,124 shares of Class A Common Stock at $0.00 per share.
After these awards, Hatchett directly held a total of 219,641 Class A shares. The transactions are coded as grants or other acquisitions rather than open-market purchases.
Nu Skin Enterprises EVP and General Counsel Chayce David Clark reported stock awards tied to performance goals being met. On February 10, 2026, he acquired 15,667 Class A shares and another 75,466 Class A shares at $0.00 per share as performance-based restricted stock units became eligible for vesting. Following these awards, he directly holds 315,224 Class A shares.
Nu Skin Enterprises’ Chief Financial Officer James D. Thomas reported equity awards tied to performance goals being met. On February 10, 2026, he acquired 9,847 Class A common shares at $0.00 when 2024 performance-based restricted stock units became eligible to vest.
On the same date, 2025 performance-based restricted stock units also met their criteria, adding a further 47,436 Class A shares at $0.00. Following these grants, Thomas directly owned 192,723 Class A common shares, reflecting increased alignment with shareholders through stock-based compensation.
Nu Skin Enterprises President and CEO Ryan S. Napierski reported performance-based equity awards in Class A common stock. On February 10, 2026, he acquired 42,970 shares and 206,988 shares at a stated price of $0.00 per share through grants classified as awards or other acquisitions.
The Form 4 shows his directly held Class A common stock rising to 686,403 shares after the first transaction and 893,391 shares after the second. Footnotes explain these awards relate to restricted stock units granted in February 2024 and February 2025, which became eligible for vesting once Nu Skin met specified performance criteria on February 10, 2026.
Nu Skin Enterprises reported fourth-quarter and full-year 2025 results within guidance, with profitability improving despite lower sales. 2025 revenue was $1.49 billion, down 14.3% from 2024, while diluted EPS rose to $3.18 (or $1.27 excluding the Mavely gain and other charges) from a loss of $(2.95).
Fourth-quarter revenue was $370.3 million, down 16.9%, but EPS improved to $0.29 from $(0.73) as gross margin expanded and restructuring costs fell. Customers declined 10%, and sales leaders fell 19%. For 2026, the company guides revenue to $1.35–$1.50 billion and EPS of $0.80–$1.20, expecting a return to year-over-year revenue growth by year-end driven by its Prysm iO wellness platform and an anticipated India market launch.
Charles Schwab Investment Management Inc. has reported a beneficial ownership stake in Nu Skin Enterprises, Inc. Class A common stock. The firm holds 2,621,785 shares, representing 5.37% of the class as of the event date 12/31/2025.
Schwab reports sole power to vote and dispose of all 2,621,785 shares, with no shared voting or dispositive power. It certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Nu Skin.